Christian Meier, MD

Professor of Endocrinology

Position:
Associate Professor (Endocrinology), Medical Faculty, University of Basel Consultant for calcium and bone metabolism, Div. of Endocrinology, Diabetology & Metabolism, University Hospital Basel

Date of birth
November 30, 1964

Address:
Klinik für Endokrinologie, Diabetologie & Metabolismus, Universitätsspital Basel
Petersgraben 4, CH-4031 Basel, Switzerland
Website: Opens external link in new windowwww.unispital-basel.ch
and
Endonet, Endokrinologische Praxis & Labor
Osteologisches Universitätsforschungszentrum DVO
Missionsstrasse 24, CH-4055 Basel, Switzerland
phone: +41 (61) 264 97 97, fax: +41 (61) 264 97 96
e-mail: Opens window for sending emailchristian.meier(at)unibas.ch
Website: Opens external link in new windowwww.endonet.ch



Academic appointments

1990–1992 Neurorehabilitation, Swiss Paraplegic Center, Basel
1992–1993 Dept. of Surgery, University Hospital, Basel
1993–1996 Dept. of Internal Medicine, University Hospital, Basel
1997 Board Certification in Internal Medicine (FMH)
1996–1998 Thyroid Research Unit, University Hospital, Basel (Research Fellow)
1998–1999 Div. of Endocrinology, Diabetes & Clinical Nutrition, Dept. of Medicine, University Hospital, Basel
2000 Board Certification in Endocrinology and Diabetology (FMH)
1999–2002 Div. of Endocrinology, Diabetes & Clinical Nutrition, Dept. of Medicine, University Hospital, Basel
2002–2004 Bone Research Program, ANZAC Research Institute, University of Sydney, Australia (Research Fellow)
2002–2004 Bone Clinic, Dept. of Endocrinology & Metabolism and Andrology Clinic, Concord Hospital Medical Centre, University of Sydney, Concord NSW, Australia
2009 Venia legendi for Endocrinology
2005– Endocrine Practice & Laboratory (Endonet), Basel, Switzerland
2005– Division of Endocrinology, Diabetes & Metabolism, Dept. of Medicine, University Hospital, Basel
2015 Professor for Endocrinology, Medical Faculty, University Basel


Other professional activities

2007–2014

Swiss Society of Endocrinology & Diabetology (SGED): Board Member

2009–2014 Swiss Menopause Society: Board Member
2008–

Swiss Society against Osteoporosis (SVGO): Board Member 2008-, President 2012-

2009–

Osteologie Akademie GmbH (OSTAK): Wiss. Beirat

2012–

Swiss Bone and Mineral Society (SBMS): Board Member

2013–

Schweizer Vereinigung Osteogenesis imperfecta (SVOI): Medical AB Member

2014–

International Osteoporosis Foundation (IOF): Member CSA

2015–

Deutsche Gesellschaft für Osteologie (DGO): Board Member

2016–

Dachverband deutschspr. osteolog. Gesellschaften e.V. (DVO): Board Member



Other memberships

Endocrine Society
American Society for Bone & Mineral Research (ASBMR)
European Calcified Tissue Society (ECTS)
Deutsche Akademie der osteologischen Wissenschaften (DAdorW)
Swiss Society for Internal Medicine (SGIM-SGAIM)



Research

  • Clinical research in metabolic bone disease, specifically in male osteoporosis, diabetes-related bone disease, drug-induced osteoporosis
  • Pharmacoepidemiology related to bone and collagen disease
  • Evaluation and application of biochemical markers in metabolic bone disease



Selected recent publications:

Meier C, Nguyen T, Handelsman DJ et al. Endogenous sex hormones and incident fracture risk in older men: The Dubbo Osteoporosis Epidemiology Study. Arch Intern Med 2008; 168: 47–54.

Meier C, Kraenzlin ME, Bodmer M et al. Use of thiazolidinediones and fracture risk. Arch Intern Med 2008; 168: 820–825.

Meier C, Brauchli YB, Jick SS et al. Use of depot medroxyprogesterone acetate and fracture risk. J Clin Endocrinol Metab 2010; 95: 4909–4916.

Kraenzlin ME, Meier C. Teriparatide and Parathyroid Hormone in the Treatment of Osteoporosis. Nat Clin Pract Endocrinol Metab 2011; 7: 647–656.

Sieber P, Lardelli P, Kraenzlin C, Kraenzlin M, Meier C. Intravenous bisphosphonates for postmenopausal osteoporosis: Safety profiles of zoledronic acid and ibandronate in clinical practice. Clinical Drug Investigation 2013; 33: 117–122.

Meier C, Kraenzlin C, Friedrich NF et al. Effect of ibandronate for the treatment of osteonecrosis of the knee: A randomized, double-blind, placebo-controlled trial. Osteoporos Int 2014; 25: 359–366.

Spoendlin C, Meier C, Jick SS, Meier CR. Oral and inhaled glucocorticoid use and risk of achilles or biceps tendon rupture. Ann Med 2015; 47: 492–498.

Meier C, Schwartz A, Egger A, Lecka-Cerna B. Effects of diabetes drugs on the skeleton. Bone 2016; 82: 93–100.

Gotthardt F, Huber C, Thierfelder C, Grize L, Kraenzlin M, Scheidegger C, Meier C. Determinants of bone mineral density in men with opioid dependence. J Bone Miner Metab 2016, in print.

Spoendlin C, Meier C, Jick SS, Meier CR. Achilles or biceps tendon rupture in women and men with type 2 diabetes mellitus. J Diab Compl 2016, in print.